newsfilter
← Latest News
GlobeNewswire·

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EQ

LA JOLLA, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that on June